Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Recent data from animal models has demonstrated that both endothelial and smooth muscle progenitor cells contribute to the development of atherosclerosis. However, no data exists concerning the presence of progenitor cells in human atherosclerotic vessels. In the present study, a range of normal and atherosclerotic human arteries were collected from patients undergoing coronary artery bypass surgery. Segments of internal mammary artery (normal controls), and segments of proximal ascending aorta with visible fatty streak were analysed. Immunofluorescence was used to detect a panel of progenitor cell markers. A small number of progenitor cells were identified within neointimal lesions and the adventitia with variable expression of CD34, stem cell antigen (Sca-1), c-kit and VEGF receptor 2 (VEGFR2) markers, but no CD133 expression. On average there was a two- to three-fold increase in progenitor cell number in the adventitia of atherosclerotic vessels compared with normal controls, with a significant difference (p<0.05) in the frequency of cells expressing VEGFR2. Thus, we have provided the first evidence that vascular progenitor cells exist within atherosclerotic lesions, and identified an increased number of progenitor cells in the adventitia of human atherosclerotic vessels. These cells might be a source for smooth muscle cells (SMCs), macrophages and endothelial cells (ECs) that form atherosclerotic lesions.

Original publication

DOI

10.1016/j.atherosclerosis.2006.05.033

Type

Conference paper

Publication Date

04/2007

Volume

191

Pages

259 - 264

Keywords

AC133 Antigen, Antigens, CD, Antigens, CD34, Aorta, Atherosclerosis, Biomarkers, Cell Count, Cell Differentiation, Cell Lineage, Cell Proliferation, Connective Tissue, Endothelial Cells, Fluorescent Antibody Technique, Indirect, Glycoproteins, Humans, Myocytes, Smooth Muscle, Peptides, Proto-Oncogene Proteins c-kit, Stem Cells, Vascular Endothelial Growth Factor Receptor-2